Skip to content
healthcare.dev

etravirine

NDC 42291-474, etravirine, tablet, from AvKARE.

Product NDC
42291-474
Status
Listed
Labeler
AvKARE
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA214196
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/42291-474 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ETRAVIRINE200 mg/1

Pharmacologic classes

Cytochrome P450 2C19 Inhibitors [MoA]; Cytochrome P450 2C9 Inhibitors [MoA]; Cytochrome P450 3A Inducers [MoA]; Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Non-Nucleoside Analog [EXT]; Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]

Package NDCNDC-11Package
42291-474-604229104746060 TABLET in 1 BOTTLE (42291-474-60)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/ea3856f6-fedf-ee88-e053-2a95a90a33ce

Use it

Look up 42291-474 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/42291-474 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 42291-474. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.